AbbVie Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Latest news
All ABBV.NE news ›AbbVie’s Dividend Keeps Climbing. Is It Still a Buy for Income Investors?
AbbVie's stock has surged nearly 29% this year, but a rising share price compresses the yield even as the dividend keeps growing. Before adding shares for income, consider what the pending Apogee deal and lingering debt load could mean…
Forget High-Yield Traps: AbbVie Is the Dividend King to Buy and Hold Through Any Rate Cycle
Not all high-yield dividend stocks are created equal. Some are genuine income compounders, while others are traps. And the current environment, with interest rates on the rise, makes it more difficult to differentiate the good from the…
AbbVie to Present Data at the 2026 European Society for Medical Oncology (ESMO) Congress Highlighting Progress Across its Expanding Solid Tumor Portfolio
Details on key presentations at ESMO 2026 are available below and the full abstracts are available through the congress online program. Approved medicines and investigational assets referenced are being evaluated in ongoing clinical trials…
Here's How Many Shares of AbbVie You'd Need for $5,000 in Yearly Dividends
AbbVie (ABBV +0.71%), which accounts for 6.2% of my portfolio, is one of my favorite long-term dividend stocks. The pharmaceutical giant has raised its dividend annually for 53 consecutive years, making it a Dividend King that has…
AbbVie presents long-term IBD drug data at European gastroenterology meeting
AbbVie (NYSE: ABBV) presented 20 scientific abstracts from its inflammatory bowel disease portfolio at the 2026 United European Gastroenterology Week, held October 17-20 in Barcelona, Spain, according to a company statement. Data from the…
1,939 AbbVie Inc. $ABBV Shares Acquired by IFP Advisors Inc
Shares of AbbVie stock opened at $285.32 on Monday. AbbVie Inc. has a 52 week low of $190.75 and a 52 week high of $291.40. The stock has a 50 day moving average price of $262.74 and a two-hundred day moving average price of $239.41. The…
AbbVie or Altria: The One Dividend Stock I’d Hold for the Next 10 Years
89Stocker, towfiqu barbhuiya via Canva AbbVie (ABBV) lowered its 2026 earnings guidance in a filing on Oct. 5. Adjusted EPS is now expected at $13.76 to $13.96, down from $13.87 to $14.07, reflecting $1.25 billion of acquired IPR&D and…
Abbvie, Vertex lead $32B September biopharma M&A surge
BioWorld News Abbvie, Vertex lead $32B September biopharma M&A surge These are cookies necessary for the services to function and are always active. They are usually only set in response to actions made by the user which amount to a…
AbbVie Inc. $ABBV Stock Sold by Fulcrum Wealth Advisors LLC
Posted by Tristan Rich on Oct 18th, 2026 Get Our Latest Stock Report on AbbVie Shares of AbbVie stock opened at $285.32 on Friday. AbbVie Inc. has a 52-week low of $190.75 and a 52-week high of $291.40. The company has a 50 day moving…
/C O R R E C T I O N - AbbVie/
Oct 18, 2026, 21:18 ET In the news release, AbbVie to Present Data at the 2026 European Society for Medical Oncology (ESMO) Congress Highlighting Progress Across its Expanding Solid Tumor Portfolio, issued 18-Oct-2026 by AbbVie over PR…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
theglobeandmail.com35
-
marketscreener.com24
-
gurufocus.com17
-
fool.com12
-
tradingview.com10
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.